Montaldi, A. P., & Sakamoto-Hojo, E. T. (2013). Methoxyamine sensitizes the resistant glioblastoma T98G cell line to the alkylating agent temozolomide. Clinical and experimental medicine, 13(4), 279-288. https://doi.org/10.1007/s10238-012-0201-x
Chicago Style (17th ed.) CitationMontaldi, Ana P., and Elza T. Sakamoto-Hojo. "Methoxyamine Sensitizes the Resistant Glioblastoma T98G Cell Line to the Alkylating Agent Temozolomide." Clinical and Experimental Medicine 13, no. 4 (2013): 279-288. https://doi.org/10.1007/s10238-012-0201-x.
MLA (9th ed.) CitationMontaldi, Ana P., and Elza T. Sakamoto-Hojo. "Methoxyamine Sensitizes the Resistant Glioblastoma T98G Cell Line to the Alkylating Agent Temozolomide." Clinical and Experimental Medicine, vol. 13, no. 4, 2013, pp. 279-288, https://doi.org/10.1007/s10238-012-0201-x.